CONNEQT Health Limited (ASX:CQT)

Market Cap	20.53M
Revenue (ttm)	6.05M
Net Income (ttm)	-18.19M
Shares Out	570.16M
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	286,345
Average Volume	560,028
Open	0.0350
Previous Close	0.0350
Day's Range	0.0340 - 0.0350
52-Week Range	0.0260 - 0.1750
Beta	0.84
RSI	66.28
Earnings Date	Nov 27, 2025

About CONNEQT Health

CONNEQT Health Limited engages in the design, manufacture, and marketing of medical devices used in cardiovascular health management in the Americas, Europe, and the Asia Pacific. It offers SphygmoCor, a vascular biometric technology that captures central hemodynamics and arterial stiffness for noninvasive measurement of vascular biomarkers including central aortic pressures and arterial stiffness indices. The company also provides medical devices and vascular biomarkers for hypertension, cardiovascular disease, and other vascular health disord...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1994
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: CQT

Financial Performance

In 2025, CONNEQT Health's revenue was 6.05 million, a decrease of -52.76% compared to the previous year's 12.81 million. Losses were -18.19 million, 168.9% more than in 2024.